Last reviewed · How we verify
NCT06878638
Nitrate - Clopidogrel - Acute Coronary Syndrome
trial in Acute Coronary Syndromes in 20 participants. Completed in 1 April 2024.
1 January 2024
Quick facts
| Lead sponsor | Bursa Postgraduate Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 1 February 2023 |
| Primary completion | 1 January 2024 |
| Estimated completion | 1 April 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Acute Coronary Syndromes — all drugs for Acute Coronary Syndromes →
Sponsor
Bursa Postgraduate Hospital
Who can join
Adults 18 to 75, any sex, with Acute Coronary Syndromes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate whether intravenous nitrate given during non-ST-elevation myocardial infarction (non-STEMI) affects the platelet inhibition of clopidogrel.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Impact of Intravenous Nitrate Treatment on Antiplatelet Effects of Clopidogrel in Acute Coronary Syndrome Patients: A Pilot Study
MELEK M, ARI H, KARAKUŞ A, ARI S, et al · · 2025 · DOI 10.22541/au.174263962.29636460/v1 -
Impact of Intravenous Nitrate Treatment on Antiplatelet Effects of Clopidogrel in Acute Coronary Syndrome Patients: A Pilot Study.
Melek M, Ari H, Karakuş A, Ari S, et al · · 2025 · PMID 40605381 · DOI 10.1177/10742484251357147
Verify or expand the search:
- PubMed search for NCT06878638
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Coronary Syndromes
Currently open trials in the same condition.
- NCT07123181 — Oregano and Basil Leaves and Coronary Artery Disease · NA · recruiting
- NCT06927739 — Focused Orticumab Research for Treating Inflammation in Coronary Arteries · Phase 2 · recruiting
- NCT06845826 — Point-of-Care Troponin Testing in the Emergency Department · NA · recruiting
- NCT07268859 — Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea · NA · recruiting
- NCT06954103 — Mechanisms And Prognosis of Stroke-Heart Syndrome · recruiting
Other Bursa Postgraduate Hospital trials
Trials by the same sponsor.
- NCT07129122 — A Novel Technique for Percutaneous Mitral Paravalvular Leak Closure: LBBAP Lead Assisted Ventricular Septal Way · completed
- NCT06951737 — Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients · completed
- NCT05541757 — Rivaroxaban - Percutaneous Coronary Intervention · completed
- NCT04507282 — Eosinophil and Anticoagulation in COVID-19 Patients · completed
- NCT04611386 — The Effect of Contrast Agents on the Anticoagulant Properties of Oral Factor Xa Inhibitors · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06878638 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bursa Postgraduate Hospital
- Last refreshed: 17 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06878638.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing